Suchergebnisse - "Pinato, David J"

PubPharm (36)

1

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

enthalten in: Journal of hepatology | 2024

von Celsa, C. | Cabibbo, G. | Fulgenzi, C. | +69

2

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

3

Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Alessi, J. | Elkrief, A. | Ricciuti, B. | +25

CommentIn: J Thorac Oncol. 2023 Jun;18(6):682-685. - PMID 37210177

4

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Auclin, E. | Benitez-Montanez, J. | Tagliamento, M. | +24

5

The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy : A Sub-Analysis of the Spinnaker Study

enthalten in: International journal of molecular sciences | 2023

von Anpalakhan, S. | Huddar, P. | Behrouzi, R. | +14

6

Outcome of liver cancer patients with SARS-CoV-2 infection : An International, Multicentre, Cohort Study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Muñoz-Martínez, S. | Sapena, V. | Forner, A. | +52

7

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study

enthalten in: The Lancet. Oncology | 2022

von Pinato, D. | Aguilar-Company, J. | Ferrante, D. | +147

8

Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma : evaluation of safety and efficacy in a retrospective, propensity score-matched study

enthalten in: Journal for immunotherapy of cancer | 2022

von Marinelli, B. | Kim, E. | D'Alessio, A. | +23

9

Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations

enthalten in: Journal for immunotherapy of cancer | 2022

von Cortellini, A. | Ricciuti, B. | Vaz, V. | +32

10

Time-Dependent COVID-19 Mortality in Patients With Cancer : An Updated Analysis of the OnCovid Registry

enthalten in: JAMA oncology | 2022

von OnCovid Study Group | Pinato, D. | Patel, M. | +78